Anti-CASKIN2 monoclonal antibody

Pre-made anti-CASKIN2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CASKIN2/CASKIN2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2397-Ab-1/ GM-Tg-hg-IP2397-Ab-2Anti-Human CASKIN2 monoclonal antibodyHuman
GM-Tg-rg-IP2397-Ab-1/ GM-Tg-rg-IP2397-Ab-2Anti-Rat CASKIN2 monoclonal antibodyRat
GM-Tg-mg-IP2397-Ab-1/ GM-Tg-mg-IP2397-Ab-2Anti-Mouse CASKIN2 monoclonal antibodyMouse
GM-Tg-cynog-IP2397-Ab-1/ GM-Tg-cynog-IP2397-Ab-2Anti-Cynomolgus/ Rhesus macaque CASKIN2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2397-Ab-1/ GM-Tg-felg-IP2397-Ab-2Anti-Feline CASKIN2 monoclonal antibodyFeline
GM-Tg-cang-IP2397-Ab-1/ GM-Tg-cang-IP2397-Ab-2Anti-Canine CASKIN2 monoclonal antibodyCanine
GM-Tg-bovg-IP2397-Ab-1/ GM-Tg-bovg-IP2397-Ab-2Anti-Bovine CASKIN2 monoclonal antibodyBovine
GM-Tg-equg-IP2397-Ab-1/ GM-Tg-equg-IP2397-Ab-2Anti-Equine CASKIN2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2397-Ab-1/ GM-Tg-hg-IP2397-Ab-2; GM-Tg-rg-IP2397-Ab-1/ GM-Tg-rg-IP2397-Ab-2;
GM-Tg-mg-IP2397-Ab-1/ GM-Tg-mg-IP2397-Ab-2; GM-Tg-cynog-IP2397-Ab-1/ GM-Tg-cynog-IP2397-Ab-2;
GM-Tg-felg-IP2397-Ab-1/ GM-Tg-felg-IP2397-Ab-2; GM-Tg-cang-IP2397-Ab-1/ GM-Tg-cang-IP2397-Ab-2;
GM-Tg-bovg-IP2397-Ab-1/ GM-Tg-bovg-IP2397-Ab-2; GM-Tg-equg-IP2397-Ab-1/ GM-Tg-equg-IP2397-Ab-2
Products NameAnti-CASKIN2 monoclonal antibody
Formatmab
Target NameCASKIN2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CASKIN2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2397-Ag-1Recombinant multi-species CSKI2/ CASKIN2/ ANKS5B protein


    Target information

    Target IDGM-IP2397
    Target NameCASKIN2
    Gene ID57513,140721,303678,702477,483314,101100349,789036,100051742
    Gene Symbol and Synonyms1600028L06Rik,ANKS5B,CASKIN2,mKIAA1139
    Uniprot AccessionQ8WXE0
    Uniprot Entry NameCSKI2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000177303
    Target ClassificationN/A

    The target: CASKIN2, gene name: CASKIN2, also named as ANKS5B. This gene encodes a large protein that contains six ankyrin repeats, as well as a Src homology 3 (SH3) domain and two sterile alpha motif (SAM) domains, which may be involved in protein-protein interactions. The C-terminal portion of this protein is proline-rich and contains a conserved region. A related protein interacts with calcium/calmodulin-dependent serine protein kinase (CASK). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.